6 completed, 4 unknown, 3 recruiting, 2 active not recruiting. 6 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Active not recruiting 2, Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Whole body MRI: new trials by email Literature Review of Whole body MRI trials Research Report on Whole body MRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference Whole body MRI - Sarcoma | Not applicable | Not yet recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 122 | 2027-01-01 | 2026-04-29 |
| The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women Whole body MRI - HIV, Menopause | Recruiting | University of California, San Francisco | 90 | 2026-04-17 | 2026-04-22 | |
| Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System Whole Body MRI, Whole Body Ultrasound, MCD Assay - Cancer | Not applicable | Recruiting | Inova Health Care Services | 800 | 2025-02-11 | 2026-06-12 |
| Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma Whole Body MRI - Myeloma | Not yet recruiting | Guy's and St Thomas' NHS Foundation Trust | 78 | 2022-06-01 | 2022-04-29 | |
| Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA Whole body MRI - Spondyloarthritis (SpA), Whole-body MRI (WBMRI) | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 100 | 2022-01-01 | 2025-11-17 | |
| Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy SPECT CT, 18F-DCFPyL PET/CT, 18F-NaF PET/CT - Prostate Cancer | Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 | 2019-11-15 | 2023-10-31 |
| Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 Whole Body MRI - Neurofibromatosis 1, Neurofibroma | Not applicable | Active not recruiting | Children's National Research Institute | 10 | 2018-07-12 | 2021-03-02 |
| Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers whole body MRI - Metastatic Breastcancer | Not applicable | Unknown | Brugmann University Hospital | 50 | 2016-12-13 | 2020-01-18 |
| Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI - Prostate Cancer Metastatic | Phase 2 | Completed | The European Uro-Oncology Group | 66 | 2015-07-01 | 2022-04-14 |
| PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide Enzalutamide, 18-FDG PET/CT, Whole body MRI - Prostate Cancer Metastatic | Phase 2 | Completed | The European Uro-Oncology Group | 66 | 2015-02-01 | 2022-04-14 |
| Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques Whole body MRI - Prostate Cancer | Unknown | University College, London | 130 | 2015-01-01 | 2016-10-18 | |
| FOcal RECurrent Assessment and Salvage Treatment Whole Body MRI, Focal Salvage Therapy, MRI Targeted biopsies - Progression of Prostate Cancer | Phase 2 | Unknown | University College London Hospitals | 177 | 2014-04-01 | 2017-05-10 |
| Whole Body PET-MRI in Paediatric and Adolescent Lymphoma Whole Body MRI - Lymphoma | Unknown | University College, London | 25 | 2014-02-01 | 2016-10-17 | |
| 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer Fluorocholine (18F-FCH) Injection, PET scan, Whole body MRI - Prostate Cancer | Not applicable | Completed | University Health Network, Toronto | 50 | 2013-12-01 | 2017-01-13 |
| Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome Whole body MRI, Psychological questionnaires - Li-Fraumeni Syndrome | Completed | Institute of Cancer Research, United Kingdom | 88 | 2012-10-01 | 2022-03-31 | |
| Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes Whole Body MRI - Li-Fraumeni Syndrome | Not applicable | Active not recruiting | Dana-Farber Cancer Institute | 150 | 2012-03-01 | 2026-01-07 |
| LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) whole body MRI - Li Fraumeni Syndrome | Phase 3 | Completed | Gustave Roussy, Cancer Campus, Grand Paris | 107 | 2011-10-27 | 2021-02-25 |
| Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases Whole Body MRI - Breast Cancer | Completed | M.D. Anderson Cancer Center | 32 | 2007-12-01 | 2016-10-27 |
Li-Fraumeni Syndrome (3) · Prostatic Neoplasms (3) · Breast Neoplasms (1) · Carotid Artery Diseases (1) · Lymphoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Neurofibroma (1) · Neurofibroma, Plexiform (1) · Neurofibromatosis 1 (1) · Neurofibromatosis, type 4, of Riccardi (1) · Sarcoma (1) · Spondylarthritis (1)
The European Uro-Oncology Group (2) · University College, London (2) · Brugmann University Hospital (1) · Children's National Research Institute (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Dana-Farber Cancer Institute (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Inova Health Care Services (1) · Institute of Cancer Research, United Kingdom (1) · M.D. Anderson Cancer Center (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University College London Hospitals (1) · University Health Network, Toronto (1)
United States (6) · United Kingdom (4) · Belgium (2) · Netherlands (2) · Canada (1) · China (1) · France (1)
Susanne Osanto, MD PhD (2) · Allison O'Neill, MD (1) · Hashim U Ahmed, FRCS, PhD (1) · Jingfei Ma, PhD (1) · Lilja Solnes, MD (1) · Manit Arya, FRCS (1) · Mark Emberton, FRCS, MD (1) · Miriam Bornhorst, MD (1) · Nathalie Hottat, MD (1) · Paul Humphries (1) · Rebecca Abelman, MD (1) · Rebecca Kaltman, MD (1) · Rosalind Eeles, PhD (1) · Shonit Punwani (1)
PMID 28772306, PMID 31730466, PMID 35370021, PMID 37385981, PMID 37778954
K23HL178394 (1), U01CA140204 (1)